Helix Health and First Databank Partner to Provide Ireland's Leading Advanced Pharmacy Solutions

First DatabankFirst Databank (FDB), the UK's leading provider of drug knowledge bases and clinical decision support, today announced the continuation of the successful partnership with Helix Health. The contract provides Helix Health with FDB's trusted clinical databases for the next three years. Helix Health is continuing to use FDB's information within their product suite in the Republic of Ireland and UK, targeted towards hospital pharmacies and other healthcare sites. FDB's drug knowledge forms a core part of Helix Health's QicScript product range which is tailored to the community pharmacies both in the UK and Republic of Ireland.

Crevan O'Malley, group commercial manager at Helix Health explains why they decided to extend the contract; "We have dealt with First Databank for over 10 years, and they have provided us with an unfailing, high-calibre service over this period. Our customers rely on our products and services and First Databank's clinical databases form a core component to our offer. First Databank is a trusted partner of ours."

FDB's drug knowledge continues to be used within leading healthcare system vendors, hospitals and other healthcare organisations around the globe. Helix Health's product suites are trusted by over 80% of Irish hospitals and nearly 70% of Irish community pharmacies. The combination of the two companies' product strengths, provide reliable and quality solutions for Helix Health's customers. FDB's drug knowledge is featured within the QicScript product range delivering information on more than 10,000 pharmaceutical products to Helix Health's customers. Helix Health's QicScript.net product is a dispensary management system which helps pharmacists to deliver efficient, safe and cost-effective patient services. With advanced clinical support, QicScript.net allows the user to record detailed patient notes. First Databank's drug knowledge provides users with immediate access to comprehensive electronic drug information at the point-of-care which has a number of documented benefits including reduction of medication errors; reduction of costs associated with medication related harm, improved patient care, and improved efficiencies in workflow.

Darren Nichols, managing director at First Databank commented on the contract; "We are delighted that Helix Health has decided to extend their long-standing contract with us. It is testimony to our brilliant team here who provide ongoing support and clinical knowledge to support the Helix Health product range. First Databank's solutions provide clients with access to a depth and breadth of medicines information that is unmatched by any other provider and we are constantly working to develop and enhance our products to meet the market's needs. Long-standing business relationships, like this, only help to develop stronger, more innovative solutions to the market."

The partnership between FDB and Helix Health will ensure the continued development of innovative solutions and delivery of first-class services to customers in the Republic of Ireland and the UK.

Related news articles:

About First DataBank
First DataBank is the UK's leading provider of drug knowledge bases and active clinical decision support. With over 30 years' experience of maintaining, developing and integrating drug knowledge bases across the entire healthcare spectrum, First DataBank has unrivalled expertise and knowledge in this specialist field. NHS Connecting for Health has chosen First DataBank to provide drug-related clinical decision support.

Patient safety is the driving force behind our business. Through the effective integration of our products into clinical systems, we enable safer prescribing, dispensing and administration.

Our Multilex Drug Data File - the UK's most comprehensive and widely used drug knowledge base - is in daily use by thousands of healthcare professionals in the UK.

For further information visit www.firstdatabank.co.uk.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...